Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04709276
Title A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer (CHAMP)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Andrew J. Armstrong, MD
Indications

prostate adenocarcinoma

prostate carcinoma

prostate cancer

prostate neuroendocrine neoplasm

prostate small cell carcinoma

Therapies

Cabazitaxel + Carboplatin + Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.